PRESS RELEASE published on 12/11/2023 at 10:00, 2 years 1 month ago Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
PRESS RELEASE published on 11/20/2023 at 12:00, 2 years 2 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000
PRESS RELEASE published on 11/02/2023 at 11:00, 2 years 3 months ago Tryp Therapeutics Inc. Announces Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3.0 Million
PRESS RELEASE published on 10/11/2023 at 22:30, 2 years 3 months ago Tryp Therapeutics Announces Closing of Private Placement of Unsecured Convertible Debentures for Gross Proceeds of AUD$175,000
PRESS RELEASE published on 08/03/2023 at 12:00, 2 years 6 months ago Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer
PRESS RELEASE published on 08/02/2023 at 12:00, 2 years 6 months ago With Great Sadness Tryp Announces the Passing of David Tousley, Director
PRESS RELEASE published on 07/13/2023 at 12:00, 2 years 6 months ago Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 05/24/2023 at 12:00, 2 years 8 months ago Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 04/27/2023 at 12:00, 2 years 9 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000
PRESS RELEASE published on 04/12/2023 at 22:00, 2 years 9 months ago Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
Published on 02/05/2026 at 09:05, 2 hours 32 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 10 hours 2 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 11 hours 37 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 13 hours 12 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 11:16, 21 minutes ago FUCHS strengthens its presence in Türkiye with the complete takeover of the joint venture OPET FUCHS
Published on 02/05/2026 at 10:48, 48 minutes ago EQS-Adhoc: Evonik Industries AG: Executive Board adjusts dividend policy
Published on 02/05/2026 at 10:05, 1 hour 32 minutes ago VT Markets Powers Reliable Gold Trading Amid Extreme Market Volatility
Published on 02/05/2026 at 10:05, 1 hour 32 minutes ago Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese
Published on 02/05/2026 at 11:30, 7 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 17 hours 33 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 17 hours 52 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 17 hours 52 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
